Europe — EMA

Olmegan (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmegan, is a angiotensin II receptor blocker presented as a oral tablet for oral use. It treats hypertension in adult patients.

Olmesartan Medoxomil, Hydrochlorothiazide

Request sourcing

Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxomil, the active ingredient in Olmegan, is a angiotensin II receptor blocker presented as a oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Olmegan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmegan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmegan is an antihypertensive drug that works on the renin‑angiotensin system to lower blood pressure.

- Hypertension: Reduces the t t … - Heart ....\n- ... - ... - … - …

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

This ...

What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?

None

What does Olmesartan Medoxomil, Hydrochlorothiazide interact with?

....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →